The Food and Drug Administration approved Eli Lilly’s weight-loss drug Zepbound on Dec. 27 to treat sleep apnea, a common but ...

Biopharmaceutical firms engaged in developing weight-loss drugs were rewarded rather significantly in 2024. It’s what helped ...

The FDA rejected sotagliflozin (Zynquista) as an adjunct to insulin therapy for glycemic control in adults with type 1 ...

Billionaire entrepreneur and top adviser to President-elect Donald Trump, Elon Musk, touted that he has reaped the benefits of Ozempic after fellow top Trump adviser, Robert F. Kennedy Jr., suggested ...

Stay updated on the latest developments in the GLP-1 drug class, including a new generic entering the market, weight loss results, FDA decisions & cost issues.

As weight-loss drugs have exploded in popularity this past year, part of the craze has been members of the public wondering which celebrities are on Ozempic.

They initially lost 40 pounds effortlessly, but now the weight is returning and so are the craving for sweets.

This comes after both Maccabi and Meuhedet Health Services announced the same subsidy for the Mounjaro weight loss shot.

Rise of the Rest Seed Fund managing partner JD Vance speaks onstage during Day 2 of TechCrunch Disrupt SF 2018 at Moscone ...

Stock market giants including Nvidia and Walmart completed stock splits in 2024. Investors like these operations because they ...

Ozempic has gotten most of the name recognition associated with weight-loss drugs, it's not the only drug in this category ...

Tirzepatide is the active ingredient in Eli Lilly's Zepbound for obesity and Mounjaro for diabetes ... Zepbound coverage by ...